Chronic Lymphocytic Leukemia

>

Latest News

Resistance Mutations Develop Differently After Noncovalent BTK Therapy in CLL
Resistance Mutations Develop Differently After Noncovalent BTK Therapy in CLL

May 14th 2025

During a live event, Shuo Ma, MD, PhD, discussed the resistance mutation analysis of patients who had disease progression after receiving pirtobrutinib for BTK inhibitor–pretreated chronic lymphocytic leukemia.

BRUIN Trial Establishes Efficacy of Noncovalent BTK in Pretreated CLL
BRUIN Trial Establishes Efficacy of Noncovalent BTK in Pretreated CLL

May 12th 2025

Analysis Illuminates CAR T-Cell Optimization for CLL
Analysis Illuminates CAR T-Cell Optimization for CLL

April 17th 2025

Hoffmann Examines Data for 17p  Deletion in Treatment-Naive CLL
Hoffmann Examines Data for 17p Deletion in Treatment-Naive CLL

April 17th 2025

Incorporating MRD Into Monitoring After Fixed-Duration CLL Treatment
Incorporating MRD Into Monitoring After Fixed-Duration CLL Treatment

April 7th 2025

Video Series
Video Interviews
Podcasts

More News